Aminocaproic Acid In Plastic Container

Aminocaproic Acid In Plastic Container Brand names, Aminocaproic Acid In Plastic Container Analogs

Aminocaproic Acid In Plastic Container Brand Names Mixture

No information avaliable

Aminocaproic Acid In Plastic Container Chemical_Formula

C₆H₁₃NO₂

Aminocaproic Acid In Plastic Container RX_link

http://www.rxlist.com/cgi/generic/amicarpre.htm

Aminocaproic Acid In Plastic Container fda sheet

Aminocaproic_Acid_In_Plastic_Container FDA

Aminocaproic Acid In Plastic Container msds (material safety sheet)

Aminocaproic_Acid_In_Plastic_Container MSDS

Aminocaproic Acid In Plastic Container Synthesis Reference

No information avaliable

Aminocaproic Acid In Plastic Container Molecular Weight

131.173 g/mol

Aminocaproic Acid In Plastic Container Melting Point

205 ^oC

Aminocaproic Acid In Plastic Container H₂O Solubility

5.05E+005 mg/L

Aminocaproic Acid In Plastic Container State

Solid

Aminocaproic Acid In Plastic Container LogP

0.306

Aminocaproic Acid In Plastic Container Dosage Forms

Solution for injection (containing 250 mg/mL of aminocaproic acid) and tablets (500, 1000mg)

Aminocaproic Acid In Plastic Container Indication

For use in the treatment of excessive postoperative bleeding.

Aminocaproic Acid In Plastic Container Pharmacology

Aminocaproic acid works as an antifibrinolytic. It is a derivative of the amino acid lysine. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Aminocaproic Acid In Plastic Container Absorption

Absorbed rapidly following oral administration. In adults, oral absorption appears to be a zero-order process with an absorption rate of 5.2 g/hr. The mean lag time in absorption is 10 minutes. After a single oral dose of 5 g, absorption was complete (F=1).

Aminocaproic Acid In Plastic Container side effects and Toxicity

A few cases of acute overdosage with intravenous administration have been reported. The effects have ranged from no reaction to transient hypotension to severe acute renal failure leading to death. The intravenous and oral LD₅₀ were 3.0 and 12.0 g/kg respectively in the mouse and 3.2 and 16.4 g/kg respectively in the rat. An intravenous infusion dose of 2.3 g/kg was lethal in the dog.

Aminocaproic Acid In Plastic Container Patient Information

Aminocaproic Acid In Plastic Container Organisms Affected

Humans and other mammals